ANL Stock — Adlai Nortye Ltd.

Up next

FQ3-26 quarter ends

~Sep 30, 2026 Est

Equibles Rating

blended score · not investment advice

Overall

Neutral

SellHoldBuy

Technical Strong Buy Momentum Very Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High

Market backdrop VIX 15.2 · calm Equity put/call 0.64

Technical

price trend

Strong Buy

50 / 200-day cross No cross

Price vs 200-day avg +76%

above

Price vs 50-day avg +25%

above

RSI (14) 66

neutral

MACD trend Positive

52-week position 90%

near high

Volume (OBV) Confirms

volume backs price

Momentum

relative strength

Very Strong

1-month return +24%

trailing

6-month return +63%

trailing

YTD return +961%

this year

Relative strength +51%

vs S&P · 6-mo

Sentiment

smart money

Neutral

Trend (MA cross) No cross

50d $12 › 200d $9 — 50d above 200d

Institutional flow Accumulating

+62% holders QoQ · +22 funds added

Insider flow Distributing

Net -$164.6K over 90 days · 100% sells

Short interest Rising

6.67% of float · ▲ +2.9% MoM · 26.3 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

42 holders — near 3-yr high, broad support

Squeeze score 73

high risk · 0–100

Fundamentals

Limited

Not enough data for a confident read.

Quant / Vol

risk profile

Very High

Volatility 151%

annualized · 1-yr

Max drawdown −51%

past year

ATR 7.2%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Buy

0 · 3 · 4

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+76% Bullish

Price vs 50-day avg

+25% Bullish

RSI (14)

66 Neutral

MACD trend

Positive Bullish

52-week position

90% Bullish

Volume (OBV)

Confirms Neutral

Market signals — smart money & positioning

Mixed

Trend (MA cross) No cross

50d $12 › 200d $9 — 50d above 200d

Institutional flow Accumulating

+62% holders QoQ · +22 funds added

Insider flow Distributing

Net -$164.6K over 90 days · 100% sells

Short interest Rising

6.67% of float · ▲ +2.9% MoM · 26.3 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

42 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $1 Now $15 · 90% Range high $17

vs 200-day avg +76% vs 50-day avg +25%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
ANL Adlai Nortye Ltd. this stock	$909.62M	+960.6%	—	—	6.7%
VRTX Vertex Pharmaceuticals Inc / Ma	$138.79B	+20.7%	+46.2%	31.9	1.6%
REGN Regeneron Pharmaceuticals, Inc.	$83.89B	+5.6%	+20.8%	20.2	2.3%
ARGX Argenx SE	$63.81B	+24.5%	—	—	1.9%
CSLLY Csl Ltd	$60.07B	—	—	—	0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

42

% held: 41.1%
Net QoQ: +14.9M sh
Top holder: Cormorant Asset Managemen…

Held Float

View

Held by Funds

Fund positions

5

View

Short & Settlement

Short Interest Rising

Shares short

4.3M

Days to cover: 26.3d
Change: +121.9K sh

View

Short Volume

Short vol %

69%

As of: Aug 26, 2026

Short Total

View

Fails to Deliver

FTD shares

2.9K

Value: $37.5K
As of: Jul 31, 2026

View

Off-Exchange

Off-exchange %

35.7%

Week of: Jul 20, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$164.6K

Buyers / Sellers: 0 / 1

Buyers Sellers

View

Filings

SEC Filings

Latest

6-K

Filed: Aug 26, 2026
This year: 10

View

	5D	20D	120D	MTD	YTD
ANL	+5.1%	+24.4%	+63.0%	+15.9%	+960.6%
SPY	-0.4%	+5.0%	+12.4%	+2.6%	+12.3%
vs SPY	+5.5%	+19.3%	+50.6%	+13.3%	+948.2%

ANL · Adlai Nortye Ltd.

Price & Indicators

Up next

Equibles Rating

Technicals

Versus peers

At a glance

Performance